Researchers are exploring the antitumor effects of a novel glucose-conjugated bacteriochlorin for photodynamic therapy. Some studies suggest that certain compounds, such as glycol porphyrin derivatives and temoporfin, may elicit resistance to this type of therapy through different mechanisms. The development of effective photodynamic therapy agents remains an area of ongoing research.